The K303R ER-α variant apparently exhibits a hypersensitivity to oestradiol [1], a characteristic that might allow breast cancers to respond to much lower levels of oestrogenic stimulation with a subsequent impact on malignant progression and the effectiveness of anti-oestrogen treatment. The gene discussed is ESR1; the disease is breast carcinoma.